Emodin promotes GSK-3β-mediated PD-L1 proteasomal degradation and enhances anti-tumor immunity in hepatocellular carcinoma

Abstract Background Programmed death-ligand 1 (PD-L1), a prominent immune checkpoint, interacts with programmed death protein-1 (PD-1) on cytotoxic T cells within tumors and promotes immune evasion. Emodin, which is known to destabilize PD-L1 in breast cancer, has great potential for enhancing anti-...

Полное описание

Библиографические подробности

Главные авторы:	Xuemei Yang, Weiguang Chen, Haitao Sun, Weicong Chen, Wei Xu, Chunyu He, Yang Liu, Ying Kuang, Yanhao Ma, Binglian Zhong, Chaojie Li, Guohuan Li, Qingfeng Du, Songqi He
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMC 2025-08-01
Серии:	Chinese Medicine
Предметы:	Hepatocellular carcinoma Emodin PD-L1 GSK-3β
Online-ссылка:	https://doi.org/10.1186/s13020-025-01146-6
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!